Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Correspondence
  • Published:

Salvage hematopoietic cell transplantation for children with acute myeloid leukemia relapsed after first transplantation: a Japanese national registry study

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: Transplant outcomes by remission status at second hematopoietic cell transplantation and prognostic poor score.

Data availability

The original data may be available from the corresponding author upon reasonable request and with permission of the Japan Society for Transplantation and Cellular Therapy and Japanese Data Center for Hematopoietic Cell Transplantation.

References

  1. Eapen M, Giralt SA, Horowitz MM, Klein JP, Wagner JE, Zhang M-J, et al. Second transplant for acute and chronic leukemia relapsing after first HLA-identical sibling transplant. Bone Marrow Transpl. 2004;34:721–7.

    Article  CAS  Google Scholar 

  2. Christopeit M, Kuss O, Finke J, Bacher U, Beelen DW, Bornhäuser M, et al. Second allograft for hematologic relapse of acute leukemia after first allogeneic stem-cell transplantation from related and unrelated donors: the role of donor change. J Clin Oncol. 2013;31:3259–71.

    Article  PubMed  Google Scholar 

  3. Bejanyan N, Weisdorf DJ, Logan BR, Wang HL, Devine SM, de Lima M, et al. Survival of patients with acute myeloid leukemia relapsing after allogeneic hematopoietic cell transplantation: a center for international blood and marrow transplant research study. Biol Blood Marrow Transpl. 2015;21:454–9.

    Article  Google Scholar 

  4. Taga T, Murakami Y, Tabuchi K, Adachi S, Tomizawa D, Kojima Y, et al. Role of second transplantation for children with acute myeloid leukemia following posttransplantation relapse. Pediatr Blood Cancer. 2016;63:701–5.

    Article  PubMed  Google Scholar 

  5. Zuanelli Brambilla C, Lobaugh SM, Ruiz JD, Dahi PB, Goldberg AD, Young JW, et al. Relapse after allogeneic stem cell transplantation of acute myelogenous leukemia and myelodysplastic syndrome and the importance of second cellular therapy. Transpl Cell Ther. 2021;27:771 e1.

    Article  Google Scholar 

  6. Yerushalmi Y, Shem-Tov N, Danylesko I, Canaani J, Avigdor A, Yerushalmi R, et al. Second hematopoietic stem cell transplantation as salvage therapy for relapsed acute myeloid leukemia/myelodysplastic syndromes after a first transplantation. Haematologica. 2023;108:1782–92.

    Article  PubMed  Google Scholar 

  7. Atsuta Y. Introduction of transplant registry unified management program 2 (TRUMP2): scripts for TRUMP data analyses, part I (variables other than HLA-related data). Int J Hematol. 2016;103:3–10.

    Article  PubMed  Google Scholar 

  8. Bacigalupo A, Ballen K, Rizzo D, Giralt S, Lazarus H, Ho V, et al. Defining the intensity of conditioning regimens: working definitions. Biol Blood Marrow Transpl. 2009;15:1628–33.

    Article  Google Scholar 

  9. Yaniv I, Krauss AC, Beohou E, Dalissier A, Corbacioglu S, Zecca M, et al. Second Hematopoietic stem cell transplantation for post-transplantation relapsed acute leukemia in children: a retrospective EBMT-PDWP study. Biol Blood Marrow Transpl. 2018;24:1629–42.

    Article  Google Scholar 

  10. Sharma A, Li Y, Huang S, Talleur AC, Suliman A, Qudeimat A, et al. Outcomes of pediatric patients who relapse after first HCT for acute leukemia or MDS. Bone Marrow Transpl. 2021;56:1866–75.

    Article  Google Scholar 

  11. Orti G, Sanz J, Bermudez A, Caballero D, Martinez C, Sierra J, et al. Outcome of second allogeneic hematopoietic cell transplantation after relapse of myeloid malignancies following allogeneic hematopoietic cell transplantation: a retrospective cohort on behalf of the grupo espanol de trasplante hematopoyetico. Biol Blood Marrow Transpl. 2016;22:584–8.

    Article  Google Scholar 

Download references

Acknowledgements

We would like to thank all the participating patients and doctors involved in the Transplant Registry Unified Management Program in collaboration with the Japanese Data Center for Hematopoietic Cell Transplantation, Japan Society for Transplantation and Cellular Therapy, Japan Society for Pediatric Hematology and Oncology, Japan Marrow Donor Program, Cord Blood Banks and Japanese Red Cross Society.

Author information

Authors and Affiliations

Authors

Consortia

Contributions

HSak, TT, HI, AH, and YO designed the study, analyzed the data, and wrote the manuscript. HSan, MS, YK, KK, FI, NY, YC, KO, KW, AW, DH, and MN contributed to the registration. YH, KM, and KT are responsible for data management. All authors discussed and approved the manuscript.

Corresponding author

Correspondence to Hirotoshi Sakaguchi.

Ethics declarations

Competing interests

The authors declare that they have no competing interests. This study was partially supported by a grant from the National Centre for Child Health and Development (2024B-15).

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sakaguchi, H., Taga, T., Ishida, H. et al. Salvage hematopoietic cell transplantation for children with acute myeloid leukemia relapsed after first transplantation: a Japanese national registry study. Bone Marrow Transplant (2024). https://doi.org/10.1038/s41409-024-02396-y

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1038/s41409-024-02396-y

Search

Quick links